All regulations
Nonrulemaking
FDA
Open for Comments
FDA-2014-E-2328
Patent Term Extension Application for lNJECTAFER® (ferric carboxymaltose) Patent No. 7,612,109
Documents
6
Comments
0
Key Dates
Comment Period OpensFeb 24, 2015
Comment Period ClosesJun 3, 2026
Documents
| Type | Title | Status |
|---|---|---|
Notice |
Keywords
cder
7,612,109
lNJECTAFER®
ferric carboxymaltose
Novak Druce Connolly Bove + Quigg LLP
Data from Regulations.gov